|
Currently available Disease Area Reports include those on ACS, Arrythmias, Chronic CAD, Diabetes, Dyslipidemia and Heart Failure. |
To overcome daunting market barriers, pharmaceutical companies leverage their increasingly limited resources by systematically focusing the vast majority of individual, team, and franchise efforts on only the most promising product opportunities in carefully defined drug markets. To add any value to development and marketing plans they require cutting-edge resources that are equally focused, by market segment, and with detailed information about physician treatment rationale, unmet needs, emerging trends and incisive competitive analysis of products in late stage development. CVrg’s Disease Area report series delivers exactly what they need: drilling down deeply into individual disease areas and patient populations in rigorous, intense, expert analyses.
METHODOLOGY and CONTENTS
Based on a sophisticated integration of primary research (KOL depth interviews) secondary research (rigorous expert analysis), epidemiology modeling (accounting for CV risk factors, population dynamics, and new trends), and probabilistic forecasting (to manage market uncertainty) each report provides detailed analyses of disease etiology, pathophysiology, epidemiology, diagnosis, current treatment (by stage), emerging trends (and rational), products in development (all ≥ Ph II drugs profiled), unmet needs, target product profiles (minimum for FDA approval and maximum use), and market forecasts (10 year by indication and class).
CVrg Sentinel™ transforms Disease Area Reports
into fresh new publications each month. In the face of ever-changing dynamic market landscapes, CVrg provides clients with ongoing, vigilant monitoring of scientific, clinical, and commercial developments by expert consultants who evaluate events and integrate new data into up-to-date reports each month. CVrg Sentinel™ takes the hassle out of clients’ reconciling the differences between the new market reality of today and their secondary research assets that are potentially flawed by not taking into account critical new information.
CVrg Consulting Plus™
With over 2,500 pages of cutting-edge analyses already at our fingertips and ongoing rigorous study of 17 CVM disease areas in our Disease Area and Therapy Area reports, CVrg’s experts maintain a decisive advantage over other consulting firms and provides more accurate, forward-looking, and detailed market planning resources than other vendors do.
|
|
Your message was received. Thank you for contacting us with your request.
Atherosclerosis Therapy Areas
Cardiovascular Therapy Areas
CV Risk Factor Therapy Areas
